Influenza PA (224–233) – 1 mg

Overview

The Influenza PA (224, 233) peptide is a crucial component in immunological research, particularly regarding the response of CD8+ T cells to the influenza PR8 virus. This specific H-2 Db- and Kb-restricted immunodominant CTL epitope has been identified as vital for understanding T cell responses in murine models. By studying this peptide, researchers can gain insights into viral pathogenesis and immune responses, paving the way for vaccine development and therapeutic strategies against influenza.

Key Features

• Immunodominant CTL epitope from influenza PR8 virus
• Specific to H-2 Db and Kb mouse strains
• Facilitates research on T cell responses
• Produced in high purity for reliable results
• Available in 1 mg quantities for flexibility in experimental design

Specifications

FAQ

What is the primary use of Influenza PA (224, 233)?

This peptide is primarily used for studying CD8+ T cell responses to influenza PR8 virus in murine models, assisting researchers in understanding immune mechanisms and viral pathogenesis.

How is the quality of the peptide ensured?

AnaSpec guarantees high purity and consistent quality for all peptides, including Influenza PA (224, 233), through rigorous testing and quality control measures.

Can this peptide be used in combination with other substrates?

Yes, Influenza PA (224, 233) can be combined with other substrates like our PKG Substrate or Autocamtide-2 for comprehensive studies on T cell interactions and responses.

Order your Influenza PA (224, 233) today and enhance your research capabilities. With reliable delivery and proven quality, this peptide is an essential tool for your laboratory work.

Related Products

• CREBtide [KRREILSRRPSYR], 5-FAM labeled

Browse more in Peptides.